Retender radar: UK public contracts ending soon
Every contract on Find a Tender with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting — unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.
When contracts end · Medical equipments, pharmaceuticals i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
902 contracts end within 24 months, 1,006 in total · £50m published GBP value, exc. VAT, in the next 6 months (framework ceilings included, not a spend forecast).
By sector, next 6 months i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
i
When contracts here run out.
Published contracts by their end date. No end date, not counted.
A likely retender, not a certain one.
CPV division of the procedure; a contract with several divisions counts in each.
85Health and social work services81133Medical equipments, pharmaceuticals29979Business services: law, marketing, consulting19415Food, drink, tobacco15372IT services: consulting, software, internet12550Repair and maintenance services11245Construction work9790Sewage, refuse, cleaning and environmental79
Contracts ending in the next 6 months
Showing 301–315
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Brown and Burk UK Ltd
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Alissa Healthcare Research Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Sandoz
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Scope Ophthalmics Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Milpharm Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: MSN Laboratories Europe Limited
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Biocon
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: ACCORD-UK LTD
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 110 daysFramework re-let
Wave 15b - Orals (plus non-parenteral) products
NHS England · NHS & health · Nationwide (UK)
Incumbent: Medreich PLC
- Contract value
- £1ceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 31 Jan 2027 · start not published
- Reference
ocds-h6vhtk-04e2d4
- Ends · in 119 daysFramework re-letPanel · 10 suppliers
Veterinary imaging Systems
APUC Ltd · Nationwide (UK)
Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more
- Contract value
- £20mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 9 Feb 2027 · start not published
- Reference
ocds-h6vhtk-044583
- Ends · in 119 daysFramework re-letPanel · 10 suppliers
Veterinary imaging Systems
APUC Ltd · Nationwide (UK)
Panel: Aquilant Endoscopy Ltd, Canon Medical Systems, IMV imaging UK Ltd +7 more
- Contract value
- £20mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- 10 Feb 2024 → 9 Feb 2027 · 2.9 yrs
- Reference
ocds-h6vhtk-044583
- Ends · in 138 daysFramework re-letPanel · 31 suppliers
NP49425 Generic and Biosimilar Transition Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: AOP Orphan Ltd, Accord Healthcare Ltd, Amarox Limited +28 more
- Contract value
- £64mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 138 daysFramework re-letPanel · 5 suppliers
Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: Celltrion Healthcare United Kingdom Limited, Fresenius Kabi Limited, Janssen-Cilag Ltd +2 more
- Contract value
- £27mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 138 daysFramework re-letPanel · 2 suppliers
Cytokine Modulators (Omalizumab)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Panel: Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Limited
- Contract value
- £9.3mceiling for the whole framework
- Annual run-rate
- —panel, not one supplier
- Term
- Ends 28 Feb 2027 · start not published
- Reference
ocds-h6vhtk-0581ea
- Ends · in 148 daysFramework re-let
Supply of Antisera Reagents
NHS Blood and Transplant · NHS & health · Nationwide (UK)
Incumbent: Bio-Rad Laboratories Limited
- Contract value
- £1.9mceiling for the whole framework
- Annual run-rate
- —ceiling, not a run-rate
- Term
- Ends 10 Mar 2027 · start not published
- Reference
ocds-h6vhtk-038a2d
How to read the radar
- End date is the contract period end the buyer published on Find a Tender. Contracts without an end date are not on the radar.
- Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
- Incumbent is the canonical supplier on the award behind the contract. A panel (several suppliers on one award) is shown as a panel — no single incumbent is invented.
- Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
- Counts are exact from the nightly projection when you filter by horizon and sector only; any other filter shows a bounded total — exact up to 1,000 contracts, an honest “1,000+” floor above that.